Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Clinical trial NCT06938867 · RECRUITING

Trial details

NCT number: NCT06938867
Sponsor: SNIPR Biome Aps.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

E Coli Infections Allogenic Transplant Patients

Start date: 2025-02-25
Primary completion: 2026-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.